FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy
Zhoulei Li, Nicolas Graf, Ken Herrmann, Alexandra Jun, Michaela Aichler, Annette Feuchtinger, Anja Baumgart, Axel Walch, Christian Peschel, Markus Schwaiger, Andreas Buck, Ulrich Keller, Tobias Dechow
Research output: Contribution to journal › Article › peer-review
34Scopus
citations
Fingerprint
Dive into the research topics of 'FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy'. Together they form a unique fingerprint.